DENV-IN-15
DENV-IN-15 is a sulfonyl anthranilic acid derivative and a pan-serotype anti-dengue virus (DENV) inhibitor with broad-spectrum anti-RNA virus activity. The EC50 value of DENV-IN-15 against DENV-2 in Huh-7 cells is 0.7 μM. DENV-IN-15 selectively regulates the translation of mRNAs encoding translation-related proteins and containing a 5'-oligopyrimidine tract. DENV-IN-15 reduces the expression of specific ribosomal proteins, thereby inhibiting viral replication. DENV-IN-15 exhibits enhanced membrane permeability, human plasma stability and human liver microsomal metabolic stability. DENV-IN-15 is applicable to research related to dengue virus infection.
For research use only. We do not sell to patients.
- Formula: C28H34N4O3S
- Molecular Weight:506.66
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
DENV-IN-15 (compound 7; 48 h) acts as a pan-serotypic DENV inhibitor in Huh-7 cells, with EC50 values of 0.14 μM (DENV-1), 0.03 μM (DENV-3), and 0.09 μM (DENV-4)[1].
DENV-IN-15 inhibits ZIKV replication in Huh-7 cells, with an EC50 of 0.12 μM at 24 h[1].
DENV-IN-15 (0.0488-50 μM; 48 h) inhibits EV71 replication in SH-SY5Y cells, with an EC50 of 0.10 μM[1].
DENV-IN-15 exhibits favorable in vitro ADME properties, with a Papp of 2.93 × 10-6 cm/s, excellent plasma stability, a human liver microsome half-life of 59.8 min, and a CLint of 18.8 mL·min-1·kg-1[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Huh-7 cells
-
Concentration:10 μM
-
Incubation Time:24 h (starting 6 h post-transfection)
-
Result:Significantly reduced ectopic Flag-NS5 protein expression driven by the wild-type 5′-TOP motif.
Had no effect on Flag-NS5 expression from the mutant 5′-TOP motif-driven construct.
In Vivo
DENV-IN-15 (10 μM; 2 or 4 days) exhibits no cytotoxicity against human brain organoids[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Embryonic stem cell-derived dorsal forebrain cortical organoids (day 60, early maturation stage)[1]
-
Dosage:5 μM
-
Administration:in culture media; single dose post-infection; up to 96 hours
-
Result:Reduced ZIKV infection by approximately 70% at 48 hours post-infection.
-
Animal Model:Embryonic stem cell-derived dorsal forebrain organoids[1]
-
Dosage:10 μM
-
Administration:in culture media; single dose; 2 or 4 days
-
Result:Showed no detectable cytotoxicity at 2 days or 4 days post-treatment, with cell viability comparable to untreated controls.
Chemical Information
-
Molecular Weight 506.66
-
Formula C28H34N4O3S
-
SMILES
O=C(NCC1CCCCC1)C2=CC(N3CCCCC3)=CC=C2NS(C4=C(N=CC=C5)C5=CC=C4)(=O)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Transepithelial/transendothelial electrical resistance assay
TEER measures electrical resistance across epithelial or endothelial monolayers cultured on permeable supports, and the readout reflects ionic conductance through the cell barrier, especially the paracellular pathway regulated by junctional integrity. TEER can be measured without destroying the monolayer and is commonly used before or during transport, permeability, barrier-disruption, and barrier-maturation experiments. TEER values are influenced by biological maturation and technical conditions; reported factors include temperature, medium formulation, passage number, electrode geometry, membrane properties, and junctional length during early monolayer maturation. Therefore, TEER should be interpreted with blank-insert subtraction, area normalization, repeated readings, and, when possible, orthogonal barrier readouts such as FITC-dextran flux or tight-junction staining.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)